RN7SL268P

Across TCGA pan-cancer cohorts, RN7SL268P RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RN7SL268P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL268P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL268P is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, CHOL, and KIRP are the cancer types where RN7SL268P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL268P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	−0.890	<.001	10	view →
CHOL	All	All	+1.286	<.001	5	view →
KIRP	All	All	−0.794	.001	5	view →
BRCA	All	II,III,IV	+0.370	.002	4	view →
THCA	All	III,IV	−0.555	.007	3	view →
UCEC	All	III,IV	+1.080	.047	2	view →
STAD	Male	II,III,IV	+0.575	.017	2	view →
LUAD	Female	All	+0.405	.033	2	view →
LIHC	Male	All	+0.401	<.001	2	view →
COAD	All	All	+0.349	.008	2	view →
READ	Female	All	+0.540	.043	1	view →
HNSC	Female	All	+0.324	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RN7SL268P–KIRC

Open the KIRC breakdown →